← FDA DRUG APPROVALS

FDA ANDA · ANDA076378

NIACIN

Sponsor: BARR

APPLICATION
ANDA076378
TYPE
ANDA
ORIGINAL APPROVAL
2005-04-26
LATEST ACTION
2015-07-07
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Prescription

Products

NIACINPrescription
NIACIN 500MG · TABLET, EXTENDED RELEASE · ORAL
NIACINPrescription
NIACIN 750MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2015-07-07Labeling · Supplement 13 · standardAP
2013-09-11Manufacturing (CMC) · Supplement 11 · unknownAP
2007-12-20Labeling · Supplement 5AP
2007-09-19Labeling · Supplement 4AP
2005-04-26OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →